Skip to main content

Table 1 Antiplatelet Therapy

From: Clinical results of bioresorbable drug-eluting scaffolds in short and long coronary artery lesions using the PSP technique

Antiplatelet therapy

Lesion length < 20 mm 190

Lesion length ≥ 20 mm 136

ASS + Clopidogrel

126 (66.3)

79 (58.1)

ASS + Prasugrel

50 (26.3)

38 (27.9)

ASS + Ticagrelor

13 (6.8)

16 (11.8)

ASS + OAK

1 (0.5)

1 (0.7)

Clopidogrel + OAK

0

2 (1.5)

  1. OAK oral anticoagulation, data are presented as number of patients (percentage of patients)
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us